Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-AnalysisXinlin Chen, Fengbin Liu, Jiangtao Hou et al.|BioDrugs|2016Cited by 13
Oncogene-induced senescence and senescence-associated secretory phenotype (SASP) determine the efficacy of palbociclib in PIK3CA mutated colorectal cancerPingping Cao, Fan Lin, Xiaorong Liu et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0
Genome-wide CRISPR/Cas9 screen identified MCL1 as a senolytic target for clearing palbociclib-induced senescent and PD-L1-positive cells in colorectal cancerHaiyang Wang, Fan Lin, Tianqi Shen et al.|SSRN Electronic Journal|2025Cited by 0